PHAP1 Antikörper
-
- Target Alle PHAP1 (ANP32A) Antikörper anzeigen
- PHAP1 (ANP32A) (Acidic (Leucine-Rich) Nuclear phosphoprotein 32 Family, Member A (ANP32A))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PHAP1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Reacts with synthetic peptide corresponding to amino acids at carboxy terminus of human PHAP I
- Aufreinigung
- Antigen affinity purified
- Immunogen
- Synthetic peptide from human ANP32A.
- Isotyp
- IgG
- Top Product
- Discover our top product ANP32A Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: IHC - P (10 μg/mL), WB (0.5 - 2 μg/mL)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS, Sodium azide 0.02 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted.
-
- Target
- PHAP1 (ANP32A) (Acidic (Leucine-Rich) Nuclear phosphoprotein 32 Family, Member A (ANP32A))
- Andere Bezeichnung
- ANP32A (ANP32A Produkte)
- Hintergrund
- Implicated in a number of cellular processes, including proliferation, differentiation, caspase-dependent and caspase-independent apoptosis, suppression of transformation (tumor suppressor), inhibition of protein phosphatase 2A, regulation of mRNA trafficking and stability in association with ELAVL1, and inhibition of acetyltransferases as part of the INHAT (inhibitor of histone acetyltransferases) complex. Plays a role in E4F1-mediated transcriptional repression.
- UniProt
- P39687
-